Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle Osteoarthritis
Recruiting in Palo Alto (17 mi)
+18 other locations
Overseen byJudith Baumhauer, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Cartiva, Inc.
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether Agilus is safe and effective in the treatment of mild to moderate ankle osteoarthritis.
Eligibility Criteria
Inclusion Criteria
18 years or older
Chronic, unilateral ankle pain(i.e., in only one ankle) for at least 6 months
Diagnosis of ankle OA confirmed by radiographs (X-ray)and clinical exam
See 1 more
Treatment Details
Interventions
- Agilus (Hyaluronic Acid)
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: ActiveActive Control1 Intervention
Agilus (Hyaluronic Acid)
Group II: ControlPlacebo Group1 Intervention
Normal Saline
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of PennsylvaniaPhiladelphia, PA
Orthopedic Associates of Grand RapidsGrand Rapids, MI
Rhode Island HospitalProvidence, RI
Brigham Foot and Ankle CenterBoston, MA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Cartiva, Inc.Lead Sponsor